OS Therapies Incorporated
OSTX News Today: Stay Updated with the Latest OS Therapies Incorporated News in Real Time
Find OSTX news now at Meyka AI. Stay informed with the latest OS Therapies Incorporated stocks updates, including price news, market analysis, and expert insights.
6255.T stock JPY 770.00 pre-market ahead of 04 Apr 2026 earnings: EPS in focus
Pre-market update on 6255.T stock at JPY 770.00 ahead of April 8 earnings; EPS and guidance in focus
CSL.AX Stock Today April 04: Pivot, Guidance Intact as Sales Rebound
CSL share price watch: guidance intact, early US and China sales recovery, and improving technicals place CSL stock ASX back on radar for Australian investors today.
William Blair: Market Perform for CSL (Carlisle Companies Incorporated) Mar 2026
William Blair maintained Market Perform on CSL. CSL analyst rating update March 2026
BofA Unveils 10 US Stock Picks for Q2 as Market Pullback Creates Opportunities
As the US equity market experiences a mild pullback in early 2026, BofA analysts are highlighting opportunities for long‑term investors. BofA has released a new set of 10 recommended US stocks that it believes could benefit from current valuations and broader economic trends. These picks reflect strong fundamentals, sector growth potential, and positioning in future‑oriented…
4840.T stock up 34.01% to JPY 788 on JPX Apr 2026: high volume momentum
Market closed: 4840.T stock rose 34.01% to JPY 788 on JPX Apr 2026 on heavy volume and overbought technicals
Evercore ISI Maintains Negative on MA (Mastercard Incorporated) March 2026
Evercore ISI maintains Negative on MA; read implications of the MA analyst rating and Meyka AI market analysis
Biogen to Buy Apellis in $5.6 Billion All‑Cash Deal
Biotech giant Biogen announced a major deal to acquire Apellis Pharmaceuticals for $5.6 billion in cash, marking one of the largest strategic transactions in the sector this year. The acquisition is aimed at strengthening Biogen’s drug pipeline, especially in areas such as eye disease and immunology where Apellis has developed promising therapies. Investors reacted strongly…
Centessa Shares Soar Following Lilly’s $6.3B Acquisition Announcement
The stock market reacted strongly after a major acquisition announcement involving Centessa Shares. Eli Lilly, one of the largest pharmaceutical companies in the world, confirmed it will acquire Centessa Pharmaceuticals for $6.3 billion in an all‑cash deal. This news caused Centessa Shares to surge sharply, making the acquisition one of the most talked‑about deals in…
March 31: JAXA Astronaut Satoshi Furukawa Retires, Spotlights Space MedTech
Satoshi Furukawa JAXA retirement on March 31 spotlights space medicine Japan. He becomes Kyorin University professor after 366 days in space, creating new medtech and research links investors should,